FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361298630> ?p ?o ?g. }

• W4361298630 endingPage "15" @default.
• W4361298630 startingPage "1" @default.
• W4361298630 abstract "The pathogenesis of osteoarthritis (OA) is complex and there is no specific drug for treatment. The aim of this study was to identify the molecular targets of OA therapy, focusing on the expression and biological functions of miR-182-5p and its target genes in OA.miR-182-5p and fibroblast growth factor 9 (FGF9) were overexpressed or knocked down in IL-1β-induced chondrocytes. An OA knee model was performed by surgically destroying the medial meniscus. The gene expression of miR-182-5p and FGF9 was calculated. The protein FGF9 was tested by western blotting. Cell counting kit-8 (CCK8), plate cloning assay, and flow cytometry were conducted to evaluate cell proliferation and apoptosis. The expression of inflammatory factors, tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, and interleukin (IL)-8, was evaluated using enzyme-linked immunosorbent assay (ELISA). Dual-luciferase reporter assays validated the targeting relationship between miR-182-5p and FGF9. Hematoxylin-eosin (HE) and safranin O-fast Green (S-O) staining were utilized to access cartilage damage. Ki67 expression in cartilage was detected using immunohistochemistry (IHC). TdT-mediated dUTP nick-end labeling (TUNEL) assays were used to calculate the apoptosis rate of cartilage.The expression of miR-182-5p was upregulated, and FGF9 was downregulated in the IL-1β-induced chondrocytes. OA chondrocytes proliferation ability in the miR-182-5p mimics group was decreased, and the apoptosis rate and inflammatory factor were increased. Transfection with miR-182-5p inhibitor increased the proliferative ability and decreased the apoptosis rate in the IL-1β-induced chondrocytes. Transfection with miR-182-5p inhibitor reversed IL-1β-induced inflammatory factor release in chondrocytes. Targeted binding sites existed between miR-182-5p and FGF9. After overexpression of FGF9, the miR-182-5p effect on OA chondrocytes was reversed. The hyaline cartilage thickness and proteoglycan content decreased in OA rats, and this was reversed by miR-182-5p inhibitor treatment.miR-182-5p expression levels were increased in OA chondrocytes and regulated chondrocyte proliferation, apoptosis, and inflammation by targeting FGF9. miR-182-5p is a potential gene for OA treatment." @default.
• W4361298630 created "2023-03-31" @default.
• W4361298630 creator A5011083267 @default.
• W4361298630 creator A5012742324 @default.
• W4361298630 creator A5021320089 @default.
• W4361298630 creator A5026436272 @default.
• W4361298630 date "2023-03-29" @default.
• W4361298630 modified "2023-09-30" @default.
• W4361298630 title "Inhibition of miR-182-5p Targets FGF9 to Alleviate Osteoarthritis" @default.
• W4361298630 cites W2011038175 @default.
• W4361298630 cites W2100261712 @default.
• W4361298630 cites W2146236251 @default.
• W4361298630 cites W2151922790 @default.
• W4361298630 cites W2483493672 @default.
• W4361298630 cites W2590831457 @default.
• W4361298630 cites W2752563562 @default.
• W4361298630 cites W2772861026 @default.
• W4361298630 cites W2797070673 @default.
• W4361298630 cites W2801016424 @default.
• W4361298630 cites W2885111578 @default.
• W4361298630 cites W2886485146 @default.
• W4361298630 cites W2890451991 @default.
• W4361298630 cites W2894820514 @default.
• W4361298630 cites W2902029697 @default.
• W4361298630 cites W2908918388 @default.
• W4361298630 cites W2910093369 @default.
• W4361298630 cites W2954555739 @default.
• W4361298630 cites W2962800749 @default.
• W4361298630 cites W2979872515 @default.
• W4361298630 cites W2986998757 @default.
• W4361298630 cites W3015521839 @default.
• W4361298630 cites W3027686686 @default.
• W4361298630 cites W3042292554 @default.
• W4361298630 cites W3057278952 @default.
• W4361298630 cites W3089141365 @default.
• W4361298630 cites W3093632051 @default.
• W4361298630 cites W3099791310 @default.
• W4361298630 cites W3111446071 @default.
• W4361298630 cites W3111918526 @default.
• W4361298630 cites W3118641273 @default.
• W4361298630 cites W3119439135 @default.
• W4361298630 cites W3120040178 @default.
• W4361298630 cites W3121753088 @default.
• W4361298630 cites W3151522506 @default.
• W4361298630 cites W3164029151 @default.
• W4361298630 cites W3195498360 @default.
• W4361298630 cites W4225725288 @default.
• W4361298630 doi "https://doi.org/10.1155/2023/5911546" @default.
• W4361298630 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37035017" @default.
• W4361298630 hasPublicationYear "2023" @default.
• W4361298630 type Work @default.
• W4361298630 citedByCount "1" @default.
• W4361298630 countsByYear W43612986302023 @default.
• W4361298630 crossrefType "journal-article" @default.
• W4361298630 hasAuthorship W4361298630A5011083267 @default.
• W4361298630 hasAuthorship W4361298630A5012742324 @default.
• W4361298630 hasAuthorship W4361298630A5021320089 @default.
• W4361298630 hasAuthorship W4361298630A5026436272 @default.
• W4361298630 hasBestOaLocation W43612986301 @default.
• W4361298630 hasConcept C105702510 @default.
• W4361298630 hasConcept C153911025 @default.
• W4361298630 hasConcept C170493617 @default.
• W4361298630 hasConcept C185592680 @default.
• W4361298630 hasConcept C190283241 @default.
• W4361298630 hasConcept C196795494 @default.
• W4361298630 hasConcept C2780550940 @default.
• W4361298630 hasConcept C502942594 @default.
• W4361298630 hasConcept C553184892 @default.
• W4361298630 hasConcept C55493867 @default.
• W4361298630 hasConcept C62112901 @default.
• W4361298630 hasConcept C74373430 @default.
• W4361298630 hasConcept C77390185 @default.
• W4361298630 hasConcept C86803240 @default.
• W4361298630 hasConceptScore W4361298630C105702510 @default.
• W4361298630 hasConceptScore W4361298630C153911025 @default.
• W4361298630 hasConceptScore W4361298630C170493617 @default.
• W4361298630 hasConceptScore W4361298630C185592680 @default.
• W4361298630 hasConceptScore W4361298630C190283241 @default.
• W4361298630 hasConceptScore W4361298630C196795494 @default.
• W4361298630 hasConceptScore W4361298630C2780550940 @default.
• W4361298630 hasConceptScore W4361298630C502942594 @default.
• W4361298630 hasConceptScore W4361298630C553184892 @default.
• W4361298630 hasConceptScore W4361298630C55493867 @default.
• W4361298630 hasConceptScore W4361298630C62112901 @default.
• W4361298630 hasConceptScore W4361298630C74373430 @default.
• W4361298630 hasConceptScore W4361298630C77390185 @default.
• W4361298630 hasConceptScore W4361298630C86803240 @default.
• W4361298630 hasFunder F4320322843 @default.
• W4361298630 hasLocation W43612986301 @default.
• W4361298630 hasLocation W43612986302 @default.
• W4361298630 hasLocation W43612986303 @default.
• W4361298630 hasOpenAccess W4361298630 @default.
• W4361298630 hasPrimaryLocation W43612986301 @default.
• W4361298630 hasRelatedWork W2053020665 @default.
• W4361298630 hasRelatedWork W2352875985 @default.
• W4361298630 hasRelatedWork W2358337505 @default.
• W4361298630 hasRelatedWork W2363045816 @default.
• W4361298630 hasRelatedWork W2368062056 @default.

• next